M Anttila
Overview
Explore the profile of M Anttila including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Ek-Kommonen C, Rudback E, Anttila M, Aho M, Huovilainen A
Vet Microbiol
. 2003 Jan;
92(3):289-93.
PMID: 12523990
Cases of canine distemper (CD) related to vaccination of exotic carnivores extend over three decades and have been described in at least nine different species. Our report describes a case...
22.
Laine K, Anttila M, Nyman L, Wahlberg A, Bertilsson L
Eur J Clin Pharmacol
. 2001 Jun;
57(2):137-42.
PMID: 11417445
Objectives: To address the relevance of cytochrome P-450 (CYP) 2C19 polymorphism for the pharmacokinetics and dynamics of selegiline and its two known primary metabolites, desmethylselegiline and l-methamphetamine. Methods: Six extensive...
23.
Kivisto K, Wang J, Backman J, Nyman L, Taavitsainen P, Anttila M, et al.
Eur J Clin Pharmacol
. 2001 May;
57(1):37-42.
PMID: 11372588
Objective: To characterise the effects of itraconazole, a potent inhibitor of CYP3A4, on the pharmacokinetics of selegiline in healthy volunteers. Methods: In this randomised, placebo-controlled crossover study with two phases,...
24.
Immunologic and hematologic properties of antibodies to prothrombin and plasminogen in a mouse model
Puurunen M, Palosuo T, Lassila R, Anttila M, Vaarala O
Lupus
. 2001 Mar;
10(2):108-15.
PMID: 11237122
Antibodies to prothrombin have been associated with venous and arterial thrombosis, and they cross-react with a structurally closely related protein plasminogen. We immunised 16 mice with human prothrombin and 15...
25.
Penttila T, Vuola J, Puurula V, Anttila M, Sarvas M, Rautonen N, et al.
Vaccine
. 2001 Jan;
19(9-10):1256-65.
PMID: 11137265
Immune responses induced by intramuscular DNA immunization with Chlamydia pneumoniae genes coding for the major outer membrane protein (MOMP), cysteine-rich outer membrane protein 2 (Omp2) or the heat shock protein...
26.
Launonen V, Mannermaa A, Stenback F, Kosma V, Puistola U, Huusko P, et al.
Cancer Genet Cytogenet
. 2000 Dec;
122(1):49-54.
PMID: 11104033
Tumor specimens from 78 epithelial ovarian cancer patients were examined for loss of heterozygosity (LOH) at 11 microsatellite markers at chromosomes 3p14.2, 6q27, 8p12, 11p15.5, 11q23.1-q24, 16q24.3, and 17p13.1, to...
27.
Vaarasmaki M, Hartikainen A, Anttila M, Pramila S, Koivisto M
Early Hum Dev
. 2000 Aug;
59(1):61-70.
PMID: 10962168
A population-based birth cohort including 296 consecutive type 1 diabetic births in a geographically defined catchment area was used to evaluate factors predicting poor perinatal and neonatal outcome. Though perinatal...
28.
Saari S, Rasi J, Anttila M
Acta Vet Scand
. 2000 Aug;
41(1):101-4.
PMID: 10920481
No abstract available.
29.
Braybrooke J, Vallis K, Houlbrook S, Rockett H, Ellmen J, Anttila M, et al.
Cancer Chemother Pharmacol
. 2000 Jul;
46(1):27-34.
PMID: 10912574
Purpose: Expression of P-glycoprotein (Pgp), which confers the multidrug resistance (MDR) phenotype, is thought to contribute to the insensitivity of renal cell cancer (RCC) to chemotherapy. The development of Pgp...
30.
Taavitsainen P, Anttila M, Nyman L, Karnani H, Salonen J, Pelkonen O
Pharmacol Toxicol
. 2000 Jun;
86(5):215-21.
PMID: 10862503
Although being a drug therapeutically used for a long time, the enzymatic metabolism of selegiline has not been adequately studied. In the current work we have studied the cytochrome P450...